Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players├óÔéČÔäó financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Antihelminthics Companies

Antihelminthics companies focus on the development of medications and therapies for the treatment of helminthic infections, which are parasitic worm infestations. These companies contribute to infectious disease management and global health by providing anthelmintic drugs that target and eliminate parasitic worms in humans and animals.

Antihelminthics Key Companies

 

Latest Antihelminthics Companies Update

 

Jan 2024


Johnson & Johnson Collaborating with WHO and other partners on the "Transform 80/20" initiative aiming to treat 80% of school-aged children with STHs by 2025.Investing in research and development of new long-acting antihelminthics for improved efficacy and reduced treatment frequency in mass drug administration programs.


Merck & Co. Received FDA approval for their new once-daily antihelminthic medication, MECTIZAN® (ivermectin), for treating onchocerciasis (river blindness).Partnering with non-profit organizations to expand access to MECTIZAN® in affected communities and contribute to onchocerciasis elimination efforts.


Eisai Co. Announced the availability of their broad-spectrum anthelminthic, praziquantel, in a chewable tablet formulation, aiming for improved medication adherence among children and addressing swallowing difficulties.Joined the WHO initiative "Global Platform for Accelerating Elimination of Soil-Transmitted Helminthiasis" to contribute to research and development efforts.


GlaxoSmithKline (GSK) Launched a new educational campaign raising awareness about helminthic infections and the importance of preventive measures like sanitation and hygiene practices.Collaborated with local governments and healthcare providers to strengthen infrastructure and healthcare systems in high-burden areas for effective worm control strategies.


List of Antihelminthics Key Companies in the Market



  • Abbott

  • Novartis AG

  • ZEISS International

  • Johnson & Johnson Services, Inc.

  • Sanofi

  • Merck & Co., Inc.

  • GlaxoSmithKline plc.

  • Astellas Pharma Inc.

  • Bayer AG

  • Mentis Pharma Ltd.

  • Pfizer Inc.

  • Sanofi

  • ALLERGAN

  • AstraZeneca


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.